Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Live long and prosper.

John S Lazo1

  • 1Department of Pharmacology, University of Pittsburgh, E1340 Biomedical Science Tower, Pittsburgh, PA 15261-0001, USA. lazo@pitt.edu

Molecular Pharmacology
|August 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting PTP4A3 with KVX-053 mitigates alcohol-amplified SARS-CoV-2 spike protein-induced acute lung injury.

Frontiers in pharmacology·2026
Same author

The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice.

Respiratory research·2025
Same author

KVX-053, a protein tyrosine phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 spike protein subunit 1-induced acute lung injury in mice.

The Journal of pharmacology and experimental therapeutics·2025
Same author

Deletion of PTP4A3 phosphatase in high-grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release.

The Journal of pharmacology and experimental therapeutics·2025
Same author

KVX-053, a Protein Tyrosine Phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 Spike protein subunit 1 - induced acute lung injury in mice.

The Journal of pharmacology and experimental therapeutics·2024
Same author

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.

Nature medicine·2024
Same journal

Regulation of organic anion transporting polypeptide 1B1 transport function by lysine deacetylase 6.

Molecular pharmacology·2026
Same journal

Neuroprotective in vitro effects of histone deacetylase 6-selective inhibitor SW-100 toward oxaliplatin-derived toxicity.

Molecular pharmacology·2026
Same journal

Emerging roles of platelet DNA in cancer detection and noninvasive prenatal testing.

Molecular pharmacology·2026
Same journal

Binding affinities for histamine receptors 1 to 4: Systematic comparison of ligands from the Psychoactive Drug Screening Program K<sub>i</sub> database and International Union of Basic and Clinical Pharmacology/British Pharmacological Society Guide to Pharmacology.

Molecular pharmacology·2026
Same journal

Molecular pharmacology of mGlu<sub>7/8</sub> heterodimers reveals unique properties of orthosteric agonists and positive allosteric modulators.

Molecular pharmacology·2026
Same journal

Effects of ivermectin on the activation and desensitization of the human GABA<sub>A</sub> receptor.

Molecular pharmacology·2026
See all related articles

Mouse embryonic stem cells express multiple Src family kinases (SFKs). Selective inhibition of SFKs can control stem cell self-renewal and differentiation, offering potential therapeutic applications.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Developmental Biology

Background:

  • Embryonic stem cells (ESCs) hold great promise for regenerative medicine.
  • Understanding the molecular mechanisms governing ESC self-renewal and differentiation is crucial for their therapeutic application.
  • The role of Src family kinases (SFKs) in ESCs is not fully understood.

Discussion:

  • This study presents the first comprehensive analysis of SFK expression patterns in mouse ES cells.
  • Seven of eight mammalian SFK members are expressed in self-renewing ES cells.
  • SFK expression changes dynamically during early differentiation, with Hck transcript levels decreasing significantly.

Key Insights:

  • SFKs like Fyn and Src remain active during ES cell differentiation.

Related Experiment Videos

  • Pharmacological inhibition of specific SFKs can modulate ES cell self-renewal and differentiation.
  • This provides a novel strategy for controlling ES cell fate.

    • Outlook:

    • Findings offer insights into the mechanisms governing ES cell pluripotency and differentiation.
    • Potential applications in regenerative medicine and the development of novel therapeutics.
    • Further research into SFK signaling pathways in stem cells is warranted.